Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Interleukin-7 Influences FOXP3+CD4+ Regulatory T Cells Peripheral Homeostasis

Abstract

Mechanisms governing peripheral CD4+ FOXP3+ regulatory T cells (Treg) survival and homeostasis are multiple suggesting tight and complex regulation of regulatory T cells homeostasis. Some specific factors, such as TGF-β, interleukin-2 (IL-2) and B7 costimulatory molecules have been identified as essentials for maintenance of the peripheral Treg compartment. Conversely, Treg dependency upon classical T cell homeostatic factors such as IL-7 is still unclear. In this work, we formally investigated the role of IL-7 in Treg homeostasis in vivo in murine models. We demonstrated that IL-7 availability regulated the size of peripheral Treg cell pool and thus paralleled the impact of IL-7 on conventional T cell pool. Moreover, we showed that IL-7 administration increased Treg cell numbers by inducing thymic-independent Treg peripheral expansion. Importantly the impact of IL-7 on Treg expansion was detected whether conventional T cells were present or absent as IL-7 directly participates to the peripheral expansion of Treg after adoptive transfer into lymphopenic hosts. Our results definitively identify IL-7 as a central factor contributing to Treg peripheral homeostasis, thus reassembling Treg to other T cell subsets in respect of their need for IL-7 for their peripheral maintenance.

Citation: Simonetta F, Gestermann N, Martinet KZ, Boniotto M, Tissières P, Seddon B, et al. (2012) Interleukin-7 Influences FOXP3+CD4+ Regulatory T Cells Peripheral Homeostasis. PLoS ONE 7(5): e36596. https://doi.org/10.1371/journal.pone.0036596

Editor: Ana Claudia Zenclussen, Otto-von-Guericke University Magdeburg, Germany

Received: December 21, 2011; Accepted: April 10, 2012; Published: May 7, 2012

Copyright: © 2012 Simonetta et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: This work was supported by the ANRS (Agence Nationale de la recherche contre le SIDA et les hépatites virales) and Fondation de France. Federico Simonetta was also supported by the FRM (Fondation pour la recherche médicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

CD4+ CD25+ FOXP3+ regulatory T cells are a population of CD4 T cells crucial for the regulation of immune responses and in preventing autoimmunity and chronic inflammation [1]. Mice and humans genetically deficient in Treg cells as a result of mutations in Foxp3, a critical transcription factor for Treg development and function, typically present severe lympho-proliferation and immune pathology [2]–[5]. Treg exert their major role in the maintenance of immune-tolerance through several mechanisms including secretion of inhibitory molecules, suppression of antigen-presenting cells function, cytolysis and effector cells metabolic disruption [6]. Despite the importance of the Treg compartment for the maintenance of immune tolerance and the intensive investigation focusing on Treg cell biology during the last few years, uncertainties remain about the factors controlling peripheral Treg survival and homeostasis. While Treg homeostasis appears to rely on some subset specific factors such as TGF-β [7]–[9], IL-2 [10]–[13] and B7 costimulatory molecules [14], [15], their dependency upon factors classically involved in conventional T cells homeostasis such as IL-7 signaling still remains controversial. IL-7 plays a critical role in T cell development and peripheral homeostasis [16]. All major CD4 T cell subsets, including naïve, memory and Th17 CD4 T cells, strictly rely on IL-7 for their peripheral homeostasis [17]–[20]. The only important exception seems to be represented by CD4+ FOXP3+ Treg which have been reported to express low levels of the IL-7 receptor alpha chain (CD127) [21]–[23]. Accordingly, peripheral Treg biology is believed to be essentially independent of IL-7/IL-7Rα signaling [17], [24]–[28] although Bayer et al suggested that IL-7 could contribute to Treg homeostasis when IL-2 signaling is disrupted [24]. However, we and others have previously shown that in vitro IL-7 treatment induces significant STAT5 phosphorylation in Tregs [26], [29]–[31] and that IL-7 is able to increase in vitro Treg survival [30], [32], [33]. These in vitro data revealing a potential role of IL-7 on Treg homeostasis need to be substantiated by in vivo analysis. We first considered Treg homeostasis in mice exhibiting altered IL-7 signaling pathway using IL-7Rα−/−, IL-7−/− or IL-7 Tg mice. Regarding the increasing development of IL-7 based therapies we also investigated how in vivo Treg homeostasis was affected following IL-7 injection. We demonstrated that IL-7 availability regulated the size of the peripheral Treg cell pool and that Treg and Tconv were equally affected following IL-7 injection. Moreover, we showed that IL-7 administration increased Treg cell numbers by inducing a thymic-independent peripheral expansion. Importantly the impact of IL-7 on Treg expansion was detected whether conventional T cells were present or absent as IL-7 directly participates to the peripheral expansion of Treg after adoptive transfer into lymphopenic hosts. Collectively, our data identify IL-7 as a central factor contributing to Treg peripheral homeostasis. Such a conclusion has major implications for the development of IL-7 based strategies to ameliorate immune-reconstitution in lymphopenic settings while preventing immune pathology.

Results

IL-7 availability affects the size of the conventional and regulatory T cell pools to a similar extent

To provide an exhaustive analysis of the influence of IL-7 on Treg homeostasis in vivo, we first examined mice in which IL-7 signaling was genetically disrupted (IL-7Rα−/− or IL-7−/−) or increased (IL-7 Tg). Because IL-7 directly impacts thymic cellularity, both thymic and peripheral Treg distribution and cellularity were determined. In agreement with previous reports [26], [27], IL-7Rα−/− mice display similar percentages of thymic FOXP3+ cells among single positive CD4 cells when compared to normal C57Bl/6 mice (3.43%±0.76% in IL-7Rα−/− versus 3.33%±0.24% in WT) while IL7−/− mice present slight though statistically significant reduction in proportion of FOXP3+ cells among CD4 T cells (2.62±0.23%, p 0.003) (Fig. 1A). Conversely, significantly higher percentages of Treg were observed in thymi from IL-7 Tg mice (5.16±0.48%, p<0.0001) (Fig. 1A). Study of absolute thymic T cell numbers revealed that the expected reduction in FOXP3− CD4+ single positive thymocytes in IL-7Rα−/− or IL-7−/− mice was associated to a proportional reduction in the FOXP3+ CD4+ single positive compartment (Fig. 1B). Accordingly IL-7 over-expressing mice presented higher numbers of both FOXP3− and FOXP3+ CD4+ single positive thymocytes. Collectively these data suggest that IL-7 signaling similarly affects conventional T cells (Tconv) and Treg cell thymic development. We then focused on splenocytes in order to evaluate IL-7 contribution in controlling Treg cell peripheral cell numbers. As already described, higher percentages of FOXP3+ cells were found among splenic CD4 T cells from IL-7Rα−/− and IL-7−/− mice when compared to control C57Bl/6 mice (Fig. 1A) (27.18%±4.23% in IL-7Rα−/− and 28.26%±0.99% in IL-7−/− versus 14.09%±1.09% in WT; p<0.0001). Such a difference is presumably linked to impaired peripheral survival of conventional naïve CD4 T cells in the absence of IL-7 signaling and suggests a lower impact of IL-7 on Treg. Interestingly, IL-7 Tg mice presented preserved proportion of splenic Treg cells among CD4 T cells (17%±3.62%) (Fig. 1A). Analyzing T cells numbers, we observed as expected that conventional CD4+ FOXP3− T cell numbers were significantly reduced in IL-7Rα−/− and IL-7−/− mice (13.8-fold and 5.4-fold reduction respectively) while they were present in higher numbers in IL-7 Tg mice (WT 7.5×106±2.8×106 vs IL-7 Tg 27.9×106±5.0×106, p<0.0001) (Fig. 1B). Accordingly, IL-7Rα−/− and IL-7−/− mice presented significantly reduced but yet substantial numbers of peripheral Treg cells compared with their wild type counterparts (WT 1.2×106±0.4×106 vs IL-7Rα−/− 0.2×106±0.1×106 vs IL-7−/− 0.5×106±0.1×106), while IL-7 Tg mice presented a 4.7-fold increase in Treg cell number (Fig. 1B). Interestingly the extent of Treg number variation in spleen from KO or Tg mice reflected the variation we observed in the conventional FOXP3− CD4 T cell compartment. Due to the crucial role of IL-7 on thymic development, these results do not allow drawing any conclusion on the direct impact of IL-7 on peripheral T cell homeostasis. Nevertheless, these results suggest that IL-7 similarly affects conventional and regulatory T cell numbers by acting on thymic development and/or peripheral homeostasis.

thumbnail
Download:
Figure 1. IL-7 signaling is involved in both thymic development and peripheral maintenance of Foxp3+ Treg.

(A) Representative dot plots of FOXP3 expressing cells gated on CD4+ CD8− TCRβ+ thymocytes and splenic CD4+ TCRβ+ cells from normal B6, IL-7Rα−/−, IL-7−/− and IL-7 Tg animals. Numbers in each dot plot indicate the relative percentages of FOXP3 cells among CD4+ T cells for representative animal selected among 4 to 6 mice per group. (B) Absolute numbers of CD4+ FOXP3+ T cells from normal B6, IL-7Rα−/−, IL-7−/− and IL-7 Tg animals. Each point represents a single mouse and mean values are indicated for each groups. Experiments were repeated independently twice with four to six mice per group; the data shown are representative of one experiment. The degree of statistical significance (p values), relative to normal B6 numbers, is indicated.

https://doi.org/10.1371/journal.pone.0036596.g001

IL-7/αIL-7 complexes treatment induces both conventional and regulatory T cells expansion

To better assess the peripheral role of IL-7, we determined the effects of exogenous IL-7 treatment on Treg cells. C57Bl/6 mice were injected with IL-7/αIL-7 complexes or PBS at d0, d2 and d4. Such a treatment protocol has been reported to induce strong peripheral expansion of conventional CD4 and CD8 T cells in non-lymphopenic hosts [25]. Flow cytometry analysis at day 7 from the first injection revealed a slight but significant reduction in the percentage of FOXP3+ CD4 T cells in the lymph-nodes (NT 11.1%±1.0% vs IL-7 9.2%±1.1%, p = 0.044) that was not detected in the spleen (NT 10.8%±1.4% vs IL-7 11.4%±0.6%, p = 0.586) (Fig. 2A). When considering absolute numbers, IL-7 treatment increased both CD4+ FOXP3− and FOXP3+ cell numbers (approximately 2 fold increase in both LN and SP) (Fig. 2B). Similarly to the analysis in mice bearing disrupted or increased IL-7 signaling (Fig. 1), conventional and regulatory T cells thus appeared similarly affected by IL-7 injection treatment. Theoretically, increase in peripheral T cell numbers results from effects on peripheral proliferation, cell survival and/or thymic production. Total and Treg thymic cellularity were not significantly different in IL-7/αIL-7 treated animals compared to PBS injected animals (data not shown). To exclude any potential contribution of thymopoiesis on observed IL-7 effects, we adoptively transferred CFSE stained CD4 T cells from CD45.1 mice into CD45.2 C57Bl/6 mice prior to IL-7 complexes treatment. Use of CD45.1 and FOXP3 staining allowed us to distinguish progeny of adoptively transferred cells from host cells (Fig. 3A). At day 7, a two-fold expansion was observed in FOXP3+ CD4+ transferred CD45.1 Treg cells isolated from IL-7 complexes treated mice when compared to PBS injected mice (Fig. 3B). Collectively, these data demonstrate that IL-7 impacts peripheral Treg homeostasis.

thumbnail
Download:
Figure 2. IL-7 complexes treatment induced both conventional and regulatory T cell expansion.

C57Bl/6 mice were i.p. injected with PBS or IL-7/anti-IL-7 complexes (1 µg rmIL-7 plus 5 µg M25) three times at 2 day intervals. LN and SP cells were analyzed 7 days after the first injection. (A) Representative dot plots of CD25 vs FOXP3 expression on CD4+TCRβ+ cells recovered from PBS or IL-7 complexes treated mice. (B) Total number of CD4+TCRβFOXP3− conventional T cells (left panels) and CD4+ TCRβ FOXP3+ regulatory T cells (right panels) from lymph nodes and spleen.

https://doi.org/10.1371/journal.pone.0036596.g002

thumbnail
Download:
Figure 3. IL-7 induced expansion of both conventional and regulatory T cells is thymic independent.

CFSE labeled total CD4 T cells from CD45.1 mice were transferred into CD45.2 C57Bl/6 hosts. Mice were then treated with IL-7/anti-IL-7 complexes as in Fig. 2. (A) Representative dot plots of CD45.1 vs FOXP3 expression on CD4+ TCRβ cells recovered from lymph nodes and spleens of PBS or IL-7 complexes treated mice. (B) Total numbers of adoptively transferred CD45.1 FOXP3− conventional T cells (left panels) and CD45.1 FOXP3+ regulatory T cells (right panels) from lymph nodes and spleen.

https://doi.org/10.1371/journal.pone.0036596.g003

IL-7/αIL-7 complexes treatment affects the Treg proliferative fraction

We next questioned whether IL-7 treatment affected Treg proliferation as described for conventional T cells.

We examined Ki67 staining, which identifies proliferating cells, in C57Bl/6 mice injected or not with IL-7/αIL-7 complexes. The fraction of cycling conventional CD4 T cells was 4 fold increased in lymph nodes reaching 22.3%±3.3% of conventional T cells, whereas the Treg proliferating fraction was slightly but significantly affected (NT 15.5%±2.1% vs IL-7 18.2%±2.4%, p = 0.0344) (Fig. 4A). Similar observation was obtained when analyzing splenic conventional T cells and Treg cells. We next evaluated the contribution of peripheral cell proliferation in the observed expansion of CD45.1 T cells transferred into C57Bl/6 mice, as described in Fig. 3. We analyzed the CFSE dilution profile of adoptively transferred cells isolated from LN at day 7. IL-7 complexes treatment induced an increase in the CFSElow proliferating fraction in both conventional (NT 5.8%±0.6% vs IL-7 18.8%±8.2%, p = 0.0191) and Treg cell (NT 17.7%±3.7% vs IL-7 26.5%±4.6%, p = 0.0252) compartments (Fig. 4B). Similar observation was obtained when splenic conventional and Treg cells were analyzed. In accordance to data obtained with the Ki67 staining, increase in proliferation upon IL-7 treatment was more important in Tconv than in Treg cell compartments. Collectively, these results indicate that IL-7 therapy affects both conventional and regulatory T cell numbers and acts at different extent on their proliferation.

thumbnail
Download:
Figure 4. IL-7 mildly impacts CD4+CD25+ Treg cells proliferative capacity.

Unmanipulated C57Bl/6 mice (A) or C57Bl/6 mice transferred with CFSE labeled total CD45.1 CD4 T cells (B) were i.p. injected with PBS or IL-7/anti-IL-7 complexes (1 µg rmIL-7 plus 5 µg M25) three times at 2 day intervals. (A) Percentage of cells expressing the proliferation marker Ki67 in CD4+ TCRβ+FOXP3− conventional T cells and CD4+ TCRβ FOXP3+ regulatory T cells from LN (left panel) and spleen (right panel). Percentage of Ki67 positive cells were determined based on isotype control. Results were pooled from 2 separate experiments, using three to four mice per group. (B) Representative CFSE profiles of CD45.1 Tconv and Treg isolated at day 7 from PBS or IL-7 complexes treated mice. Experiments were repeated independently three times with two to four mice per group. Data shown are representative of one experiment.

https://doi.org/10.1371/journal.pone.0036596.g004

IL-7 directly induces Treg peripheral expansion in lymphopenic hosts

Treg survival is highly dependent on IL-2 [12], [13]. Increase in Treg cellularity upon IL-7 treatment may reflect increased IL-2 production by the proliferating conventional/effector cells fraction. To formally address the direct impact of IL-7 on Treg biology, we used adoptive transfer into lymphopenic hosts, in which Treg expansion could be observed in the absence of potential IL-2 producing conventional T cells. We first transferred purified CFSE labeled CD4+ CD25+ cells into IL-7 competent or deficient empty hosts (Rag−/− or Rag−/− IL-7−/− mice) (Fig. 5). Treg recovered from spleen of both groups were identified by FOXP3 intracellular staining at day 1 and 6 (Fig. 5A). Importantly, similar proportions of FOXP3− non Treg cells were detected in the two groups of recipient mice suggesting similar impact of potential contaminating effector T cells (Fig. 5B). We first analyzed the CFSE dilution profile of injected Tregs in both hosts. Higher proportion of dividing FOXP3+ Tregs was evident in IL-7 competent hosts compared to IL-7 deficient hosts (Fig. 5C). However, number of division undergone by Tregs did not significantly differ: most dividing Tregs have undergone more than 7 divisions in both Rag−/− and Rag−/− IL-7−/− recipients. We next analyzed absolute Treg cell recovery from recipients spleen. At day 1, Treg cell numbers recovered from spleen were slightly but statistically different between IL-7 deficient and IL-7 competent hosts. Such higher splenic homing in Rag−/− IL-7−/− recipients presumably reflects the absence of LN structures in the absence of IL-7. Conversely, Treg cells numbers recovered at day 6 were significantly higher in Rag−/− hosts compared to Rag−/− IL-7−/− hosts (Fig. 5B). Notably, day 6 Treg recovery in IL-7 competent hosts was increased compared to day 1, whereas Treg numbers recovered in IL-7 deficient hosts were reduced compared to d1 values. In order to confirm our results while excluding the potential bias induced by co-transfer of contaminating conventional non-Treg FOXP3- cells, we adoptively transferred highly purified FACS sorted CD4+ FOXP3GFP+ cells (Fig. 5E) from mice in which a green fluorescent protein (GFP) encoding sequence was introduced under the FOXP3 promoter (Fig. 5E). Even in these conditions, significantly higher numbers of CD4+ TCRβ+ FOXP3+ Treg cells were recovered in Rag−/− hosts compared to Rag−/− IL-7−/− hosts (Fig. 5F) pointing to a direct effect of IL-7. In this setting where contamination by non FOXP3 cells can be excluded, we detected a small fraction of FOXP3 non expressing T cells at day 8. Down regulation of FOXP3 expression by Treg has been previously described following transfer into empty hosts [34]–[37]. We questioned whether IL-7 availability may affect differently Treg conversion and indirectly modulate Treg accumulation. We thus determined the percentage of Treg conversion in both hosts. At day 8, 93%±2% of CD4+ TCRβ+ cells recovered from Rag−/− hosts still expressed FOXP3GFP, suggesting limited conversion to effector FOXP3− non-Treg cells (Fig. 5G). Importantly, we did not detect any significant differences in the percentage of converted Tregs in the presence of absence of IL-7 suggesting IL-7 did not crucially affected Treg conversion (7.17%±2.19% in Rag−/− vs 5.53%±2.45% in Rag−/−IL-7−/−; p 0.6458). Collectively, these data demonstrate that Treg expansion and accumulation in lymphopenic settings is IL-7 dependent.

thumbnail
Download:
Figure 5. IL-7 promoted expansion of FOXP3+ Treg cells in lymphopenic hosts.

(A, B, C) 1.106 CFSE labeled, purified CD4+CD25+ T cells were transferred into Rag−/− and Rag−/− IL-7−/− mice. (A) Representative dot plots of FOXP3 vs TCRβ expression on splenic lymphocytes at day 6 after transfer. (B) Percentages of FOXP3+ cells among CD4+ TCRβ+ cells at day 6 after transfer. (C) Representative profiles of CFSE dilution of CD4+ TCRβ+ FOXP3+ cells at day 6 after transfer, and graph of CFSElow Tregs percentage recovered from three experiments using two to three mice per group. (D) Total splenic numbers of CD4+TCRβ+FOXP3+ cells recovered per mouse at day 1 and 6. (E,F,G) 5 105 CD4+ GFP+ cells isolated from Foxp3GFP mice were transferred into Rag−/− and Rag−/−IL-7−/− mice. (E) Representative dot plots of FOXP3GFP vs CD4 expression in FACS sorted Treg cells before transfer. (F) Total splenic numbers of CD4+TCRβ+FOXP3GFP+ cells recovered per mouse at day 8. (G) Percentages of FOXP3GFP+ cells among CD4+TCRβ+ cells at day 8 after transfer. Experiments were repeated twice with three mice per group. Data shown are representative of one experiment.

https://doi.org/10.1371/journal.pone.0036596.g005

Discussion

All major CD4 T cell subsets, including naïve, memory and Th17 CD4 T cells, strictly rely on IL-7 for their peripheral homeostasis. The only important exception seems to be represented by CD4+ FOXP3+ Treg cells, which are believed to essentially rely on other factors such as IL-2, TGF-β and costimulatory molecules. Although several γc cytokines, including IL-2, IL-4, IL-7, IL-15, IL-21, have been reported to increase Treg survival in vitro [33], only IL-2 has been clearly established as a major factor controlling Treg cell homeostasis in vivo [10]–[13], [38], [39]. Several reports investigated the role of IL-7 on thymic Treg development [24], [26], [27] and tried to extend the analysis to the peripheral effects of IL-7. Using adoptive transfer of total CD4 T cells into irradiated Rag−/− or Rag−/− IL-7−/− mice, Mazzuchelli et al, failed to detect any differences in Treg numbers recovered concluding that IL-7 availability does not affect Treg peripheral survival [26]. Unfortunately, total lymph-node cells were transferred, impeding any conclusions on the direct effect of IL-7 on Treg cells in this setting. The present study aimed to further investigate the effects of IL-7 on the homeostasis of CD25+ FOXP3+ regulatory T cells. Importantly, we demonstrated that IL-7 availability controls the size of both Tconv and Treg pools. Mice in which IL-7 signaling was impaired presented a reduction in Treg cell numbers similar to those observed in conventional T cell numbers. Conversely, IL-7 Tg mice, in which IL-7 production is constantly increased, showed an expansion of the Treg compartment. However, one may question the relevance of studies performed in mice exhibiting disruption of IL-7/IL-7R signaling, which severely impact thymic differentiation and peripheral T cell homeostasis. We next used a more relevant model allowing us determining the impact of IL-7 on physiologically generated Treg. Using IL-7 injection protocol, we confirm the impact of IL-7 on Treg homeostasis. IL-7 treatment in normal mice induced an increase in conventional CD4 T cell numbers that was strictly paralleled by an increase in Treg cell numbers. Importantly demonstrating that IL-7 levels equally affect the size of conventional and Treg subsets perfectly corroborate results obtained in humans during clinical trials investigating the effects of IL-7 therapy on immune-reconstitution in lymphopenic settings. Indeed, three published reports analyzed the proportion of Treg cells in peripheral blood from patients treated with IL-7 [40]–[42] and detected either slight reduction or no difference in the percentage of Treg cells among CD4 T cells after IL-7 treatment. Because total CD4 T cell count increased in IL-7 treated patients, essentially preserved Treg percentages indicate that Treg changes in absolute numbers also paralleled those detected in conventional CD4 T cells in human studies. We next aimed to determine the mechanisms involved in IL-7 mediated effects on Treg pool. Because the impact of IL-7 on conventional T cell proliferation [43] and survival [44] has been extensively described, we aimed to determine whether IL-7 influenced Treg homeostasis by similar mechanisms. Interestingly, IL-7 differently impacted conventional and regulatory T cell compartment: the fraction of proliferating T cells were 3-fold increased in conventional T cells, but mildly increased in Treg fraction in IL-7 treated C57Bl/6 mice. Although significant, such low increases in Treg proliferative capacity is unlikely to account for the highly significant increase in Treg cellularity upon IL-7/αIL-7 complex treatment. These results thus suggest IL-7 treatment is likely to increase Treg cell numbers in the periphery by affecting both their survival and accumulation as previously suggested [30], [32], [33] together with their proliferative capacity. Because the fraction of proliferating conventional T cells was significantly increased upon IL-7 treatment, we speculated that the beneficial impact of IL-7 on Treg homeostasis essentially rely on increased IL-2 availability due to the increased fraction of activated/effector conventional T cells. Indeed, IL-7 is highly heterogeneous in targets and mechanisms [16], favoring both conventional T cell homeostasis and effector differentiation [45], [46]. To determine the impact of IL-7 on Tregs in the absence of conventional T cells, we performed adoptive transfer of purified Treg into Rag−/− or Rag−/− IL-7−/− mice. We showed that Treg cells transferred into Rag-deficient mice lacking IL-7 proliferated and accumulated less than Treg transferred into IL-7 competent Rag-deficient mice. To note, residual proliferation was still present in the absence of IL-7 indicating that other factors participate to the phenomenon. Although residual IL-2 production by DCs or “exFOXP3” converted Treg cannot be formally excluded [37], [47], other γc cytokines may also impact Treg peripheral homeostasis [33]. We thus demonstrated the direct impact of IL-7 on Treg biology in the absence of conventional T cells. However, we cannot exclude that the impact of IL-7 on Treg homeostasis may combine both direct and indirect effects [48].

In summary, our data establish a role for IL-7 in Treg homeostasis, thus reassembling Treg to other T cell subsets in respect of their need for IL-7 for their peripheral maintenance. They indicate that IL-7 availability similarly affects both the conventional and the regulatory T cell pool, maintaining their proportions relatively unchanged. This balanced effect of IL-7 on both the conventional and the regulatory T cell pool can be important to prevent immune-pathology during both spontaneous and therapeutic IL-7 induced immune reconstitution.

Materials and Methods

Ethics Statement

Mice were kept under specific pathogen free conditions in accordance with institutional guidelines in compliance with French and European animal welfare regulations (agreement B-94-043-12, delivered by the French veterinary authorities). All animal studies were approved by the ethics Committee of University Paris Sud and protocols conducted were authorized by French veterinary authorities (licence 94-440) in accordance with French and European guidelines.

Mice

6 to 8 weeks old C57Bl/6 were purchased from Charles River (Janvier). Mice deficient for Rag gene (Rag−/−) or for Rag and IL-7 genes (Rag−/− IL-7−/−) were used as hosts for adoptive transfer experiments. IL-7Rα−/− mice were purchased from the Jackson Laboratory. IL-7−/− and IL-7 transgenic (IL-7 Tg) mice were kindly provided by Dr. Sophie Ezine. Foxp3-GFP mice were purchased from the Jackson Laboratory. All mice were kept under specific pathogen free conditions and all experiments were performed according to institutional guidelines of the European Community.

Cell purification

Single cell suspensions were prepared from lymph nodes (pooled inguinal, brachial, axillary and mesenteric) and spleens HBSS containing 2% FCS (PAA Laboratories GmbH). For total CD4 T cells transfer, CD4 T cells were isolated using BD magnetic beads (Becton-Dickinson). For CD4+ CD25+ Treg adoptive transfer experiments, CD4+ CD25+ cells were isolated by magnetic beads accordingly to manufacturer instructions (Miltenyi). Cell purity for FOXP3 was >90%. For CD4+ FOXP3+ Treg adoptive transfer experiments, CD4+ FOXP3GFP+ cells were FACS sorted from Foxp3-GFP mice (Jackson Laboratory) on a FACSAria cell sorter (BD Biosciences). Cell purity for FOXP3 was >99%.

FACS analysis

Extracellular staining was preceded by incubation with purified anti-CD16/32 antibodies (FcgRII/III block, 2.4G2) (eBioscience) to block nonspecific staining. Cells were stained with FITC-, PE-, PECy5-, PECy7-APC- APCAlexa750- or APC-H7-labeled or biotinylated appropriate antibodies including: CD4 (GK1.5); TCRβ (H57-597); CD25 (PC61.5) or appropriate isotype Abs. Streptavidin-FITC, PECy5 or PECy7 were used to develop biotinylated Abs. All Abs were purchased from eBioscience except APC-H7-labeled antibodies (BD Bioscience). Intranuclear FOXP3 staining was performed using eBioscience PE- or APC conjugated FOXP3 staining buffer set (FJK-16s). Intracellular Ki-67 staining was performed using BD Pharmingen Ki-67 (B56) on permeabilized cells. Six-color flow cytometry was performed with a FACSCanto cytometer (BD Biosciences) and data files were analyzed using FlowJo software (Tree star Inc).

CFSE labelling

When required, cell division of transferred T cells was assessed by CFSE labelling (Sigma) using standard methods. Cells were resuspended in PBS in a concentration of 107/mL and incubated with CFSE at final concentration of 5 µM for 10 min at 37°C, followed by two washes in ice cold HBSS containing 10% FCS.

Cytokines

Recombinant murine IL-7 (rmIL-7) was purchased from Immunotools and anti-IL-7 mAb M25 was purchased from BioXcell. Before injection, cytokines/antibody complexes were generated as previously described [25]. Briefly, 1 µg of cytokine was co-incubated with 5 µg of the specific monoclonal antibodies for 30 min at +37°C. Mice were i.p. injected with PBS or IL-7/anti-IL-7 complexes (1 µg rmIL-7 plus 5 µg M25) three times at 2 day intervals.

Adoptive transfer experiments

For adoptive transfer experiments into wild type mice, total CD4 T cells (7.5×106) from CD45.1 mice were transferred into CD45.2 C57Bl/6 hosts. Mice were then treated with IL-7/anti-IL-7 complexes as described. For adoptive transfer experiments into empty mice, purified CD4+ CD25+ cells (1×106) or CD4+ FOXP3GFP+ cells (5×105) were injected into Rag-deficient mice (Rag−/−) or Rag−/− mice that were also deficient for IL-7 (Rag−/− IL-7−/−). One and/or six to eight days after transfer, spleens were harvested and analyzed.

Statistical analyses

Statistical analyses were performed using unpaired Student T test with Graph Pad Software.

Acknowledgments

We thank Stéphane Bloquet and Céline Fernandes Da Silva for mice husbandry, Dr Sophie Ezine for providing mice. We thank Dr Corinne Tanchot for critical reading and helpful discussion, Pr. Marc Tardieu, Pr Jean-François Delfraissy for their support.

Author Contributions

Conceived and designed the experiments: FS CB. Performed the experiments: FS NG KM MB. Analyzed the data: FS NG KM MB CB. Contributed reagents/materials/analysis tools: MB PT BS. Wrote the paper: FS CB.

References

  1. 1. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151–1164.
  2. 2. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, et al. (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27: 20–21.
  3. 3. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, et al. (2001) Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27: 68–73.
  4. 4. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, et al. (2000) JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106: R75–81.
  5. 5. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, et al. (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27: 18–20.
  6. 6. Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133: 775–787.
  7. 7. Li MO, Sanjabi S, Flavell RA (2006) Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25: 455–471.
  8. 8. Marie JC, Letterio JJ, Gavin M, Rudensky AY (2005) TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 201: 1061–1067.
  9. 9. Marie JC, Liggitt D, Rudensky AY (2006) Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 25: 441–454.
  10. 10. Bayer AL, Yu A, Adeegbe D, Malek TR (2005) Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period. J Exp Med 201: 769–777.
  11. 11. D'Cruz LM, Klein L (2005) Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol 6: 1152–1159.
  12. 12. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY (2005) A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6: 1142–1151.
  13. 13. Setoguchi R, Hori S, Takahashi T, Sakaguchi S (2005) Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 201: 723–735.
  14. 14. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, et al. (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431–440.
  15. 15. Tang Q, Henriksen KJ, Boden EK, Tooley AJ, Ye J, et al. (2003) Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J Immunol 171: 3348–3352.
  16. 16. Fry TJ, Mackall CL (2005) The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol 174: 6571–6576.
  17. 17. Liu X, Leung S, Wang C, Tan Z, Wang J, et al. (2010) Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nat Med 16: 191–197.
  18. 18. Schluns KS, Kieper WC, Jameson SC, Lefrancois L (2000) Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 1: 426–432.
  19. 19. Seddon B, Tomlinson P, Zamoyska R (2003) Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol 4: 680–686.
  20. 20. Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, et al. (2001) IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A 98: 8732–8737.
  21. 21. Cozzo C, Larkin J , Caton AJ (2003) Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells. J Immunol 171: 5678–5682.
  22. 22. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, et al. (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203: 1701–1711.
  23. 23. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, et al. (2006) Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 203: 1693–1700.
  24. 24. Bayer AL, Lee JY, de la Barrera A, Surh CD, Malek TR (2008) A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells. J Immunol 181: 225–234.
  25. 25. Boyman O, Ramsey C, Kim DM, Sprent J, Surh CD (2008) IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T Cell expansion without lymphopenia. J Immunol 180: 7265–7275.
  26. 26. Mazzucchelli R, Hixon JA, Spolski R, Chen X, Li WQ, et al. (2008) Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP. Blood 112: 3283–3292.
  27. 27. Peffault de Latour R, Dujardin HC, Mishellany F, Burlen-Defranoux O, Zuber J, et al. (2006) Ontogeny, function, and peripheral homeostasis of regulatory T cells in the absence of interleukin-7. Blood 108: 2300–2306.
  28. 28. Vang KB, Yang J, Mahmud SA, Burchill MA, Vegoe AL, et al. (2008) IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development. J Immunol 181: 3285–3290.
  29. 29. Juffroy O, Bugault F, Lambotte O, Landires I, Viard JP, et al. (2010) Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway. J Virol 84: 96–108.
  30. 30. Simonetta F, Chiali A, Cordier C, Urrutia A, Girault I, et al. (2010) Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells. Eur J Immunol 40: 2528–2538.
  31. 31. Wuest TY, Willette-Brown J, Durum SK, Hurwitz AA (2008) The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells. J Leukoc Biol 84: 973–980.
  32. 32. Harnaha J, Machen J, Wright M, Lakomy R, Styche A, et al. (2006) Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells. Diabetes 55: 158–170.
  33. 33. Pandiyan P, Lenardo MJ (2008) The control of CD4+CD25+Foxp3+ regulatory T cell survival. Biol Direct 3: 6.
  34. 34. Duarte JH, Zelenay S, Bergman ML, Martins AC, Demengeot J (2009) Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. Eur J Immunol 39: 948–955.
  35. 35. Miyao T, Floess S, Setoguchi R, Luche H, Fehling HJ, et al. (2012) Plasticity of foxp3(+) T cells reflects promiscuous foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 36: 262–275.
  36. 36. Rubtsov YP, Niec RE, Josefowicz S, Li L, Darce J, et al. (2010) Stability of the regulatory T cell lineage in vivo. Science 329: 1667–1671.
  37. 37. Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martinez-Llordella M, et al. (2009) Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 10: 1000–1007.
  38. 38. Almeida AR, Zaragoza B, Freitas AA (2006) Indexation as a novel mechanism of lymphocyte homeostasis: the number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells. J Immunol 177: 192–200.
  39. 39. Zhang H, Chua KS, Guimond M, Kapoor V, Brown MV, et al. (2005) Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat Med 11: 1238–1243.
  40. 40. Rosenberg SA, Sportes C, Ahmadzadeh M, Fry TJ, Ngo LT, et al. (2006) IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J Immunother 29: 313–319.
  41. 41. Sereti I, Dunham RM, Spritzler J, Aga E, Proschan MA, et al. (2009) IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood 113: 6304–6314.
  42. 42. Sportes C, Hakim FT, Memon SA, Zhang H, Chua KS, et al. (2008) Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 205: 1701–1714.
  43. 43. Li WQ, Jiang Q, Aleem E, Kaldis P, Khaled AR, et al. (2006) IL-7 promotes T cell proliferation through destabilization of p27Kip1. J Exp Med 203: 573–582.
  44. 44. Jiang Q, Li WQ, Hofmeister RR, Young HA, Hodge DR, et al. (2004) Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members. Mol Cell Biol 24: 6501–6513.
  45. 45. Kondrack RM, Harbertson J, Tan JT, McBreen ME, Surh CD, et al. (2003) Interleukin 7 regulates the survival and generation of memory CD4 cells. J Exp Med 198: 1797–1806.
  46. 46. Li J, Huston G, Swain SL (2003) IL-7 promotes the transition of CD4 effectors to persistent memory cells. J Exp Med 198: 1807–1815.
  47. 47. Granucci F, Vizzardelli C, Pavelka N, Feau S, Persico M, et al. (2001) Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol 2: 882–888.
  48. 48. Grinberg-Bleyer Y, Saadoun D, Baeyens A, Billiard F, Goldstein JD, et al. (2010) Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. J Clin Invest 120: 4558–4568.